A detailed history of Meriwether Wealth & Planning, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Meriwether Wealth & Planning, LLC holds 502 shares of LLY stock, worth $375,054. This represents 0.27% of its overall portfolio holdings.

Number of Shares
502
Previous 480 4.58%
Holding current value
$375,054
Previous $371 Million 11.89%
% of portfolio
0.27%
Previous 0.26%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 21, 2025

BUY
$725.72 - $929.72 $15,965 - $20,453
22 Added 4.58%
502 $415 Million
Q4 2024

Feb 07, 2025

BUY
$727.2 - $932.06 $349,056 - $447,388
480 New
480 $371 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $710B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Meriwether Wealth & Planning, LLC Portfolio

Follow Meriwether Wealth & Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meriwether Wealth & Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meriwether Wealth & Planning, LLC with notifications on news.